ONESOURCE SPECL PHARMA L Share Price

₹ 1,558.20

-₹4.80 (-0.31%)
1D
Last updated 02 Nov, 2026, 15:58 IST
NSE: ONESOURCE
|
Pharmaceuticals

ONESOURCE SPECL PHARMA L Share Price Today

As of 2 Nov 2026, ONESOURCE SPECL PHARMA L share price is ₹1,558.20. The stock opened at ₹1,563.00, compared to its previous close of ₹1,563.00. During today's trading session, ONESOURCE SPECL PHARMA L share price moved in the range of ₹1,542.20 to ₹1,601.50, with an average price of ₹1,571.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,057.00 and a high of ₹1,925.00. On the performance front, ONESOURCE SPECL PHARMA L share price has declined by 10.35% over the last six months and is down 15.96% on a year-on-year basis.

Share price over the last 1 day fell from 1570.40 to 1565.70, ranging between 1547.00 and 1599.10.
₹1,542.20
0.31% down today
₹1,601.50
1D LOW
1D HIGH

ONESOURCE SPECL PHARMA L Stock Insights

Latest Earning
Op Profit TrendUp by 160.57% QoQ
Latest Earning
Net Profit TrendUp by 129.92% QoQ
Latest Earning
Revenue TrendUp by 14.22% QoQ
Stock Performance
OutperformingBeat Nifty by 0.81 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.02%
Shareholding Pattern
DIIDII increased stake by 0.42%
Shareholding Pattern
FIIFII increased stake by 1.36%
ONESOURCE SPECL PHARMA L stock performance
Open₹1,563.00
High₹1,601.50
Low₹1,542.20
Prev. close₹1,563.00
ONESOURCE SPECL PHARMA L trading activity
Volume3,29,034
Average traded price₹1,573.14
Last traded time03:58:55 02 Nov
Last traded quantity1
Circuit
L
H
₹1,250.40
₹1,875.60
52-week
L
H
₹1,057.00
₹1,925.00
Mkt Cap Cr
17,926.44
P/E
-11166.07
P/B
3.03
ROA
-0.02%
ROE
0.19%
ROCE
1.55%
Quick Ratio
0.68
EV/EBITDA
49.83

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
OneSource Speci. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
OneSource Speci. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
OneSource Speci. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ONESOURCE SPECL PHARMA L Company Background

ISIN
INE013P01021
Sector Market Cap
₹ 17,926.44 Cr

OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

ONESOURCE SPECL PHARMA L Financial Highlights

  • Revenue: ONESOURCE SPECL PHARMA L reported revenue of ₹1,436.61 crore in FY26 vs ₹1,462.32 crore in FY25. It showed a decrease of 1.76% on a yearly basis.
  • Operating Profit: ONESOURCE SPECL PHARMA L reported an operating loss of ₹91.96 crore in FY26 vs ₹67.07 crore in FY25. It showed a decrease of 37.11% on a year-on-year basis.
  • Net Profit: ONESOURCE SPECL PHARMA L reported a net loss of ₹73.80 crore in FY26 vs ₹17.97 crore in FY25. It showed a decrease of 310.68% on a yearly basis.

ONESOURCE SPECL PHARMA L Quarterly Result Highlights

  • ONESOURCE SPECL PHARMA L reported revenue of ₹517.19 crore in Sep 2026, compared with ₹452.82 crore in Jun 2026, representing an increase of 14.22% on a quarter-on-quarter (QoQ) basis.
  • ONESOURCE SPECL PHARMA L reported an operating profit of ₹52.87 crore in Sep 2026, compared with ₹20.29 crore in Jun 2026, representing an increase of 160.57% on a quarter-on-quarter (QoQ) basis.
  • ONESOURCE SPECL PHARMA L reported a profit of ₹57.48 crore in Sep 2026, compared with ₹25.00 crore in Jun 2026, reflecting an increase of 129.92% on a QoQ basis.
  • The earnings per share (EPS) of ONESOURCE SPECL PHARMA L stood at ₹6.44 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
30.47%
FII
19.46%
Other DII
10.45%
Retail and other
25.87%
Mutual funds
13.76%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202519.24%
Mar 202617.50%
Jun 202619.19%
Sep 202619.46%

ONESOURCE SPECL PHARMA L Investment Returns

1 day
-0.31%
1 week
+11.52%
1 month
+3.33%
1 year
-15.96%
3 years
-8.88%
5 years
-8.88%

ONESOURCE SPECL PHARMA L Share Price History

ONESOURCE SPECL PHARMA L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹1,574.80 / ₹1,563.00
-0.42%
29 Oct 26
₹1,585.00 / ₹1,569.60
-0.51%
28 Oct 26
₹1,620.00 / ₹1,577.60
-0.77%
27 Oct 26
₹1,402.70 / ₹1,589.80
+13.78%
Show more

ONESOURCE SPECL PHARMA L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,421.59₹1,444.85₹171.92₹38.71
Other Income₹15.02₹17.47₹4.23₹2.69
Total Revenue₹1,436.61₹1,462.33₹176.14₹41.41
Total Expenses₹1,518.65₹1,418.55₹425.90₹312.63
Profit Before Tax-₹91.96-₹67.07-₹365.70-₹415.65
Tax-₹18.16-₹49.79₹0.00₹0.00
Profit After Tax-₹73.80-₹17.28-₹365.70-₹415.65
EPS - Basic-₹6.44-₹1.63-₹94.15-₹200.87
EPS - Diluted-₹6.44-₹1.63-₹94.15-₹200.87

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹91.96-₹67.76-₹391.17-₹799.83
Income before WC changes₹293.80₹359.04-₹103.08-₹195.51
Change in Assets-₹457.50-₹287.99-₹77.49-₹36.86
Change in Liabilities₹180.92-₹131.89₹73.36₹58.56
Change in WC-₹276.57-₹419.89-₹4.13₹21.70
Cash flow from Operations₹8.52-₹67.85-₹107.21-₹162.88
Cash flow from Investing-₹494.98-₹201.08₹510.55-₹67.72
Cash flow from Financing₹359.44₹412.01-₹390.54₹118.32
Total Cash Flow-₹127.02₹143.07₹12.79-₹112.28
Cash (Start of the year)₹165.36₹22.26₹9.47₹121.76
Cash (End of the year)₹38.34₹165.36₹22.26₹9.47

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹6,784.07₹6,464.06₹1,132.23₹1,780.40
Current Assets₹1,425.94₹1,086.18₹176.38₹228.40
Total Assets₹8,210.01₹7,550.24₹1,308.61₹2,008.81
Current Liabilities₹1,441.97₹1,113.56₹630.59₹865.22
Net Current Asset-₹16.03-₹27.38-₹454.21-₹636.81
Non-Current Liabilities₹936.76₹556.10₹282.31₹358.14
Equity Capital₹5,831.29₹5,880.58₹395.71₹785.45
Total Equity & Liabilities₹8,210.01₹7,550.24₹1,308.61₹2,008.81

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,405.38₹1,299.59₹171.92₹38.71
Other Income₹15.01₹17.68₹4.23₹2.70
Total Revenue₹1,420.39₹1,317.27₹176.14₹41.42
Total Expenses₹1,393.76₹1,226.48₹425.14₹312.56
Profit Before Tax₹21.21-₹21.46-₹364.93-₹429.55
Tax₹0.00-₹41.46₹0.00₹0.00
Profit After Tax₹21.21₹20.00-₹364.93-₹429.55
EPS - Basic₹1.85₹1.75-₹93.97-₹200.69
EPS - Diluted₹1.85₹1.75-₹93.97-₹200.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹21.21-₹22.15-₹390.40-₹799.11
Income before WC changes₹260.42₹262.52-₹102.33-₹194.18
Change in Assets-₹489.26-₹303.13-₹79.79-₹37.15
Change in Liabilities₹280.68₹0.23₹73.13₹55.70
Change in WC-₹208.58-₹302.90-₹6.66₹18.55
Cash flow from Operations₹55.18-₹47.28-₹108.99-₹164.70
Cash flow from Investing-₹477.60-₹300.04₹505.99-₹65.68
Cash flow from Financing₹361.06₹417.22-₹384.22₹118.32
Total Cash Flow-₹61.37₹69.90₹12.78-₹112.06
Cash (Start of the year)₹92.09₹22.19₹9.41₹121.47
Cash (End of the year)₹30.72₹92.09₹22.19₹9.41

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹6,819.03₹6,366.58₹1,132.16₹1,780.23
Current Assets₹1,457.03₹1,023.88₹176.42₹228.21
Total Assets₹8,276.06₹7,390.46₹1,308.58₹2,008.44
Current Liabilities₹1,523.93₹1,069.48₹628.52₹863.59
Net Current Asset-₹66.90-₹45.60-₹452.10-₹635.38
Non-Current Liabilities₹801.91₹400.88₹282.31₹358.14
Equity Capital₹5,950.22₹5,920.10₹397.74₹786.71
Total Equity & Liabilities₹8,276.06₹7,390.46₹1,308.58₹2,008.44
* All values are in INR Crore
ONESOURCE SPECL PHARMA L market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
ONESOURCE SPECL PHARMA L technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
58.19
Neutral
ATR (14)
65.28
Neutral
STOCH(9,6)
75.21
Neutral
STOCH RSI (14)
90.62
Bearish
ADX(9)
44.14
Bearish
UO(9)
60.65
Neutral
ROC(12)
7.12
Bullish
WillR(14)
-24.79
Neutral
Period
Simple value
Exponential vaue
5D
1539.46
1533.11
10D
1454.07
1497.36
20D
1467.33
1489.24
50D
1520.83
1519.99
100D
1573.2
1546.66
Volume trend — traded volume by day
2 Nov3L
30 Oct9L
29 Oct7L
28 Oct38L
27 Oct78L
26 Oct2L
Average23L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ONESOURCE SPECL PHARMA L
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in ONESOURCE SPECL PHARMA L

Fund name
AUM
LIC MF Healthcare Fund
3.63%
Motilal Oswal ELSS Tax Saver Fund
2.99%
Mirae Asset Healthcare Fund
2.43%

ONESOURCE SPECL PHARMA L Returns Calculator

ONESOURCE SPECL PHARMA L Latest News

6 days ago
Ola Electric, Sona BLW, Onesource Specialty shares surge amid spike in volumes; check full list
1 month ago
Graphite India, Reliance Power, DLF shares spurt amid heavy volumes; check full list
Showing news item 1 of 2

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

ONESOURCE SPECL PHARMA L Share Price FAQs

Please be aware that ONESOURCE SPECL PHARMA L stock prices are subject to continuous fluctuations due to various factors.